Editorial board

Barry R Goldspiel Bethesda, MD, USA

Alexandre Chan University of California, Irvine, CA, USA
Graham Sewell (Emeritis) Plymouth University, UK

Marliese Alexander Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Australia
M. Brooke Bernhardt Baylor College of Medicine, Houston, Texas, USA
John E Brown Kingston University, UK
Carole Chambers Alberta Health Services Pharmacy, Canada
Thomas Connor Cincinnati, USA
Sylvie Crauste-Manciet University of Paris V - Rene Descartes, France
Melanie Dalby King’s College Hospital NHS Foundation Trust, London UK
Mario De Lemos BC Cancer Agency, Vancouver, Canada
George Dranitsaris Ontario Cancer Institute (OCI), Princess Margaret Hospital, Ontario, Canada
Salim Hadad Rambam Health Care Campus, Haifa, Israel
Lisa Holle University of Connecticut School of Pharmacy, Storrs, CT, USA
Sabine Kaestner University Hospital Malmo, Sweden
Esin Aysel Kandemir Carl von Ossietzky University of Oldenburg, Wiefelstede Germany
Polly E Kintzel Spectrum Health Hospitals, USA
Shereen Nabhani Kingston University, UK
Lynne Nakashima BC Cancer Agency, Vancouver Cancer Centre, Canada
Manit Saeteaw Ubon Ratchathani University, Ubon Ratchathani, Thailand
Junya Sato Shonan University of Medical Sciences, Yokohama, Japan
Rowena Schwartz University of Cincinnati, USA
Judith Smith The University of Texas Health Science Center at Houston, USA
Lindsay Stansfield Denver Health, Denver, CO, USA
Nicola Stoner Cancer Research UK, Oxford, UK
Gunter Wiedemann Oberschwabenklinik, Ravensburg, Germany
Keary Zhou The Chinese University of Hong Kong, Shatin, N.T., Hong Kong